Blackmores’ strong sales performance in Q3 FY2024 has helped parent company Kirin reduce the operating loss coming from its ...
The drug is manufactured by Japanese firm Kyowa Hakko Kirin (Kyowa Kirin), and is for adult patients with mycosis fungoides (MF) or Sézary syndrome (SS) who have received at least one prior ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback